Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide Agonist ASC35

by | PRNewswire Asia

-ASC36_35FDC, a once-monthly subcutaneous (SQ) fixed dose combination (FDC) injection of ASC36 and ASC35, is a potentially first-in-class drug candidate which targets three validated targets of amylin receptor, GLP-1R and GIPR. -ASC36 is a potentially first-in-class...

HIGHWAY HOLDINGS SIGNS MASTER AGREEMENT FOR FORMATION OF MAJORITY-OWNED ENERGY STORAGE JOINT VENTURE WITH WOWTIGER BRAND OWNER HUAHU

by | PRNewswire Asia

Expands Highway Holdings into the Energy Storage Market, Creates a Platform for Shifting Towards a Product Business, while Extending its OEM business and  Increasing Factory Utilization HONG KONG, Aug. 10, 2026 /PRNewswire/ — Highway Holdings Limited...

Dx&Vx Signs Two Material Transfer Agreements in Latin America Within Two Months — "Technology Validated Across Both Public and Private Sectors"

by | PRNewswire Asia

— Argentine biopharmaceutical company in July, South American public health institution in August sign consecutive KRNA material transfer agreements— Two of five cumulative MTAs now in Latin America, as company accelerates entry into the region’s pharmaceutical...

Ricoh Hong Kong and Halo Energy Sign Memorandum of Understanding to Build a Smart Mobility Ecosystem and Support Enterprises' Green Transformation

by | PRNewswire Asia

HONG KONG, Aug. 10, 2026 /PRNewswire/ — Hong Kong’s electric vehicle market is developing rapidly. As of the end of May 2026, the number of electric vehicles in Hong Kong had increased to approximately 178,000, accounting for around 19.4% of all vehicles...

Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer

by | PRNewswire Asia

HONG KONG, Aug. 10, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or the "Company")  announced that the first patient has been dosed in a Phase II clinical study (AK146D1-202) evaluating AK146D1, the Company’s internally...

Chinese and Indonesian cardiologists complete Southeast Asia's first "noise-free" cardiac procedure in Jakarta

by | PRNewswire Asia

JAKARTA, Indonesia, Aug. 10, 2026 /PRNewswire/ — Cardiologists from China and Indonesia have successfully completed Southeast Asia’s first complex Chronic Total Occlusion (CTO) procedure guided by United Imaging’s uAngio AVIVA angiography system. The...